Targeting MEK5 impairs nonhomologous end-joining repair and sensitizes prostate cancer to DNA damaging agents

Document Details

Document Type
Pub Defense Publication
Publication Date
Jan 24, 2020
Source ID
10.1038/s41388-020-1163-1

Entities

People

  • Axel J. Duval
  • Constantinos G Broustas
  • Howard B. Lieberman
  • Kunal R. Chaudhary
  • Renu K. Virk
  • Richard A. Friedman

Organizations

  • National Cancer Institute
  • United States Department of Defense